Clinical Trials · NCT00006359

Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Alliance for Clinical Trials in Oncology
Enrollment
63
Start date
Sep 2000
Locations
26 sites, United States
Primary endpoint
Toxicity
View Gonadorelin compound reference